InvestorsHub Logo
Followers 61
Posts 3376
Boards Moderated 1
Alias Born 12/26/2012

Re: Solantey post# 50556

Sunday, 01/27/2013 10:39:31 AM

Sunday, January 27, 2013 10:39:31 AM

Post# of 130503
Nice Find, but it wont save money it is actually an add on test that will lead the patients to the NUROPRO Blood test for biomarkers. as it is stated in the column

There are many areas of medical practice and research where we think this could have an impact -- for example, reducing the need to visit the clinic to find out how the disease is progressing. We could do high-frequency monitoring for individualized treatment decisions. This might allow clinicians to optimize drug timing and dosage. For clinical trials, we could do cost-effective mass recruitment for new treatments. By recruiting very large numbers into trials we could help speed up the search for a cure. And finally, this could enable population-scale screening programs, that might allow us to search for 'biomarkers' that show early signs of the disease before the damage done is irreparable.[/quote]